Previous 10 | Next 10 |
home / stock / clabf / clabf news
Core One Labs (OTCPK:CLABF) said its unit Vocan Biotechnologies filed patent application for protection of its Biosynthetic Production System for Psilocybin. Core One said that with Vocan’s recombinant production system, the subsidiary successfully tested its proof-of-concept for the m...
VANCOUVER, British Columbia, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (the “ Company ” or “ Core One ”) is pleased to announce that following its milestone announcemen...
VANCOUVER, British Columbia, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (the “ Company ” or “ Core One ”) is pleased to announce that its wholly owned subsidiary Akome B...
VANCOUVER, British Columbia, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU ) (“ Core One ” or the “ Company ”) is pleased to announce that its wholly owned subsidiary, Vocan...
VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“ Core One ” or the “ Company ”) announces that the special investor webcast (the “ Webcast ”...
VANCOUVER, British Columbia, Jan. 15, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“ Core One ” or the “ Company ”) is pleased to announce, as a follow up to the press release dated January 10, ...
VANCOUVER, British Columbia, Jan. 08, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU ) (“ Core One ” or the “ Company ”) is pleased to announce that it has progressed its work on bios...
VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (the “ Company ” or “ Core One ”) applauds Health Canada for its recent amendment to the Special ...
VANCOUVER, British Columbia, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “ Company ” or “ Core One ”) is a research and development company focused on bringing psychedelic medicine...
VANCOUVER, British Columbia, June 21, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company ”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“ Akome ”) has co...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 8, 2024 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 , WKN: A3CSSU ) (the " Company " or " Core One "), is pleased to announce that it has entered into a loan agreement (the " Loan Agreement ") with Right Season Investments Corp. (" Right S...
VANCOUVER, BC / ACCESSWIRE / December 8, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce the signing of an Initial Agreement (the " Agreement ") with Cube Psytech Corp. (" Cube Psytech ") marking a sig...
VANCOUVER, BC / ACCESSWIRE / December 1, 2023 / Core One Labs Inc. (" Core One " or the " Company ") (CNSX: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN: A3CSSU ), an emerging leader in the field of neuroscience and psychedelics, is delighted to share the exciting results of its first round of S...